• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 12 of 100
France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
Retail
France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
By Jurgen Hecker and AFPOctober 15, 2024
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Commentary
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
By Jeffrey Sonnenfeld and Steven TianOctober 10, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
Health
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
By Lindsey LeakeOctober 10, 2024
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits
Retail
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits
By AFPOctober 10, 2024
Some businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute
Commentary
Some businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute
By Robert BlumOctober 9, 2024
Martin Shkreli holds his head, as if he knows how much of a headache it's going to be to convince the Supreme Court to overturn his case
Politics
Martin Shkreli gets snubbed by the Supreme Court and must return millions he reaped from jacking up the price of a lifesaving drug
By Lindsay Whitehurst and The Associated PressOctober 7, 2024
Google DeepMind director of strategic initiatives, Terra Terwilliger, speaking onstage at Fortune's COO Summit.
Tech
Google DeepMind exec says AI will increase efficiency so much it’s expected to handle 50% of info requests in its legal department
By Paolo ConfinoOctober 7, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
Finance
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By Greg McKennaOctober 7, 2024
balding head
Health
Hair loss drug probed in Europe over link to suicidal thoughts
By Ashleigh Furlong and BloombergOctober 4, 2024
woman sitting in the dark looking at a light-therapy box
Mind
Bright light therapy used for Seasonal Affective Disorder can help treat other depressions too
By Beth GreenfieldOctober 2, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
Health
Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By Ryan HoggSeptember 24, 2024
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
Finance
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
By Sara Sjolin, Sanne Wass, Oliver Crook and BloombergSeptember 23, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
Health
Could it be COVID? Here are the symptoms to watch out for in 2024
By Lindsey LeakeSeptember 21, 2024
Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
Leadership
Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
By Sydney LakeSeptember 16, 2024
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
Newsletters
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
By Sheryl EstradaSeptember 10, 2024
1...
  • 10
  • 11
  • 12
  • 13
  • 14
...100
Most Popular
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
C-Suite
Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairmanplaceholder alt text
By Catherina GioinoSeptember 18, 2026
Success
Billionaire TikTok founder is now the richest person in all of Asia, with a $105 billion net worth—he's gained $92 billion since 2019 thanks to AIplaceholder alt text
By Emma BurleighSeptember 17, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.